[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
doi: 10.3322/caac.21660
|
[2] |
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2021年版)[J]. 中国癌症杂志, 2021, 31(10): 954-1040.
|
|
The Society of Breast Cancer China Anti-Cancer Association. Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2021 edition)[J]. China Oncol, 2021, 31(10): 954-1040.
|
[3] |
CAUDLE A S, GONZALEZ-ANGULO A M, HUNT K K, et al. Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer[J]. J Clin Oncol, 2010, 28(11): 1821-1828.
doi: 10.1200/JCO.2009.25.3286
|
[4] |
LIU S W, LI J C, KANG L, et al. Degradation of long non-coding RNA-CIR decelerates proliferation, invasion and migration, but promotes apoptosis of osteosarcoma cells[J]. Cancer Cell Int, 2019, 19: 349.
doi: 10.1186/s12935-019-1076-7
|
[5] |
ZHU Y, YANG Z, LUO X H, et al. Long noncoding RNA TTN-AS1 promotes the proliferation and migration of prostate cancer by inhibiting miR-1271 level[J]. Eur Rev Med Pharmacol Sci, 2021, 25(3): 1165.
|
[6] |
SHA M, LIN M, WANG J, et al. Long non-coding RNA MIAT promotes gastric cancer growth and metastasis through regulation of miR-141/DDX5 pathway[J]. J Exp Clin Cancer Res, 2018, 37(1): 58.
doi: 10.1186/s13046-018-0725-3
|
[7] |
LIU Y H, HE A B, LIU B E, et al. Potential role of lncRNA H19 as a cancer biomarker in human cancers detection and diagnosis: a pooled analysis based on 1 585 subjects[J]. Biomed Res Int, 2019, 2019: 9056458.
|
[8] |
ÖZGÜR E, FERHATOĞLU F, ŞEN F, et al. Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer[J]. Cancer Biomark, 2020, 27(1): 11-17.
doi: 10.3233/CBM-190085
|
[9] |
ZHANG K J, LUO Z L, ZHANG Y, et al. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer[J]. Cancer Biomark, 2016, 17(2): 187-194.
doi: 10.3233/CBM-160630
|
[10] |
ZHANG Y F, YAN J, LI C, et al. LncRNA H19 induced by helicobacter pylori infection promotes gastric cancer cell growth via enhancing NF-κB-induced inflammation[J]. J Inflamm (Lond), 2019, 16: 23.
doi: 10.1186/s12950-019-0226-y
|
[11] |
JERUSS J S, MITTENDORF E A, TUCKER S L, et al. Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy[J]. J Clin Oncol, 2008, 26(2): 246-252.
doi: 10.1200/JCO.2007.11.5352
|
[12] |
ROY R, PATTNAIK S, SIVAGURUNATHAN S, et al. Small ncRNA binding protein, PIWI: a potential molecular bridge between blood brain barrier and neuropathological conditions[J]. Med Hypotheses, 2020, 138: 109609.
doi: 10.1016/j.mehy.2020.109609
|
[13] |
BRANNAN C I, DEES E C, INGRAM R S, et al. The product of the H19 gene may function as an RNA[J]. Mol Cell Biol, 1990, 10(1): 28-36.
|
[14] |
SHEN X K, XIE B J, MA Z S, et al. Identification of novel long non-coding RNAs in triple-negative breast cancer[J]. Oncotarget, 2015, 6(25): 21730-21739.
doi: 10.18632/oncotarget.4419
|
[15] |
ZHOU S Y, HE Y J, YANG S J, et al. The regulatory roles of lncRNAs in the process of breast cancer invasion and metastasis[J]. Biosci Rep, 2018, 38(5): BSR20180772.
|
[16] |
WANG J, SUN J Y, YANG F. The role of long non-coding RNA H19 in breast cancer[J]. Oncol Lett, 2020, 19(1): 7-16.
|